Ticker Symbol: KTRA
Kintara Therapeutics Inc
$0.84 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001498382
Company Profile
Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide.
Sector: Manufacturing
Industry: Polish and Other Sanitation Good Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 12707 High Bluff Drive
Website: www.kintara.com
CEO: Saiid Zarrabian
Tags:
- Distribution Services
- Wholesale Distributors
- Manufacturing
- Polish and Other Sanitation Good Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $3.87
Change:
$0.00
(
-0.13%)
Days Range: $3.87 - $4.21
Beta: 0.44
52wk. High: $15.50
52wk. Low: $2.70
Ytd. Change -43.89%
50 Day Moving Average: $3.98
200 Day Moving Average: $3.73
Shares Outstanding: 1746408
Valuation
Market Cap: 675.9M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A